Although it remains controversial whether GSK3β is a “tumor suppressor” or “tumor promoter” in regulation of neoplastic transformation and tumor progression, GSK3β expression level was found to be higher in liver tumors than in normal liver tissues in a mouse model of hepatic carcinogenesis [34]. The gene discussed is GSK3B; the disease is neoplasm.